HOPKINTON, Mass., June 1, 2011 /PRNewswire/ — Caliper Life
Sciences, Inc. (NASDAQ:
CALP), a leading provider of tools and services for drug
discovery and life sciences research, hosted its 2011 annual
Customers Owners Group (COG 2011) meeting on May 17 and 18 at its
Hopkinton headquarters. This thought-leadership conference brought
together leaders in research, drug discovery, and diagnostics to
discuss the technologies and discoveries that are transforming the
detection and treatment of disease, and making personalized
medicine a reality. More than 350 customers attended the event,
which featured 45 presentations from researchers representing life
sciences companies and institutions.
“COG 2011 was a tremendous congress, with presentation tracks
focused on next generation sequencing, imaging & pathology,
biomarkers discovery, molecular diagnostics, biologics &
vaccines, and targeted small molecules, each of which is a critical
enabling theme for personalized medicine. A key message from the
meeting was the clear need for technological innovations in these
areas that can enable the precision diagnostics and therapeutics
that are required to achieve the vision of personalized medicine,”
said Kevin Hrusovsky, President and CEO of Caliper Life Sciences.
“This event highlighted Caliper’s focus on innovation,
collaboration, and culture as key cornerstones that define our
efforts to extend and improve the quality of life and to truly
place the patient first in the practice of medicine. Throughout the
event, it was our privilege to motivate and provide inspiration to
leading researchers from industry and academia, while also
demonstrating how our technologies are having a profound impact on
research applications.”
“One of the main reasons I am here today is the important
collaborations between academy and industry are going to drive this
revolution. We are in an era o
‘/>”/>
